Treatment | EROD Activity1-a |
---|---|
None | <0.09 |
Cycloheximide | <0.09 |
Actinomycin D | <0.09 |
OT | 3.1 ± 0.31-150 |
OT + cycloheximide | 25 ± 21-160 |
UVT | 6.1 ± 0.51-150 |
UVT + cycloheximide | 24 ± 11-160 |
TCDD | 16 ± 31-150 |
TCDD + cycloheximide | 42 ± 71-160 |
Hepa-1 cells were grown to >95% confluence. After adding 10 ml of fresh medium, the cells were incubated in the presence of OT or UVT (100 μM) or TCDD (2 nM) for a total of 4 h. TCDD was added in dimethyl sulfoxide (final concentration of dimethyl sulfoxide was 0.02%). Cycloheximide (5-μg/ml medium) was added during the final 2 h of oxidized tryptophan treatment. After the end of incubation, the cells were washed two times with sterile PBS and incubated for an additional period of 3 h in fresh medium (10 ml) containing actinomycin D (1 μg/ml). The cells were then washed with ice-cold PBS, scraped, collected by centrifugation, and EROD activity was determined as described in the text.